Hospice Eligibility and Referral Guidelines for Advanced Liver Cirrhosis

Eligibility Criteria

• Patients with advanced decompensated cirrhosis should be referred to hospice when they have comfort‑oriented goals and an estimated survival of ≤ 6 months, documented by progressive functional decline, refractory complications, and the cessation of curative treatments (including liver transplantation) 1.
• The estimated survival ≤ 6 months must be based on the disease’s natural course, without life‑prolonging interventions, and should be documented by the treating gastroenterology/hepatology provider 1.

Symptom Assessment

• The American Gastroenterological Association requires systematic assessment of physical, psychological, social, and spiritual symptoms in end‑stage liver disease patients 1.

Documentation Requirements

• Goals‑of‑care discussions must be recorded at sentinel events such as hospital/ICU admission, before initiation of life‑supporting therapies, at onset of new cirrhosis‑related complications, or after determination of transplant ineligibility 1.
• Prognosis should be evaluated by gastroenterology/hepatology clinicians during routine outpatient visits and at any sentinel event 1.

Barriers to Palliative Care and Hospice Referral

• Being listed for liver transplantation is the single greatest factor that impedes palliative‑care consultation for patients with end‑stage liver disease 2.
• Attending hepatologists are frequently the primary barrier to palliative‑care referral among patients who are on the transplant list 2.

Timing and Coordination of Referral

• Any patient with acute‑on‑chronic liver failure (ACLF) or an ICU admission should receive a palliative‑care consultation irrespective of transplant‑listing status 2.
• Collaborative pathways with local hospice teams and palliative‑care specialists are recommended to ensure that hospice goals of care are achieved promptly 2.

Palliative‑care is distinct from hospice; it can be provided concurrently with curative therapies throughout the disease trajectory, whereas hospice requires a documented ≤ 6‑month prognosis and a shift to comfort‑focused care [1][3].

Hospice Admission Criteria for Liver Cirrhosis

Introduction to Hospice Eligibility

• The American Gastroenterological Association recommends that patients with liver cirrhosis being admitted to hospice have a prognosis of 6 months or less with comfort-oriented goals, demonstrated through progressive functional decline, refractory complications, and evidence that curative treatments are no longer appropriate or desired 4, 5

Patient Assessment and Goals

• The American College of Gastroenterology suggests documenting explicit patient/family statement of comfort-focused goals and willingness to forgo life-prolonging interventions 4, 5
• Assessing prognostic awareness is crucial, as it helps determine if the patient understands they have a life-limiting illness with estimated survival ≤6 months 4, 6

Disease Severity and Prognosis

• The American Association for the Study of Liver Diseases recommends using the MELD-Na score to assess disease severity, with a current value and trend over the past 3-6 months 4, 7
• A Child-Pugh Class C cirrhosis is a strong indicator of hospice eligibility 4
• The CLIF-C ACLF score can be used if applicable, with scores >70 associated with ~90% 90-day mortality 8, 9

Symptom Management and Caregiver Support

• The American Gastroenterological Association suggests that symptom assessment should include physical, psychological, social, and spiritual domains 4, 6
• Caregiver burden level and support needs should be assessed, with the hospice team providing caregiver education on disease trajectory and symptom management 4, 6, 5

Hospice Enrollment and Care

• Immediate referral to hospice is recommended for patients with comfort-oriented goals and prognosis ≤6 months 4, 5
• Ensuring goals of care documentation transfers with the patient to the hospice agency is crucial 8, 9
• Confirming advance directive and code status (DNR/DNI) documentation is essential 4, 5